Osteoporosis Drugs Market Analysis By Product (Branded, Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM), Rank Ligand Inhibitors, Generics), And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1 Research Methodology & Scope
                  1.1 Region Wise Market Calculation
                     1.1.1 Region Wise Market: Base Estimates
                     1.1.2 Global Market: CAGR Calculation
                  1.2 Region based segment share calculation
                  1.3 List of Secondary Sources
Chapter 2 Executive Summary
                  2.1 Market summary
Chapter 3 Osteoporosis Drugs Market Variables, Trends & Scope
                  3.1 Market segmentation& scope
                     3.1.1 Market Driver Analysis
                     3.1.2 Market Restraint Analysis
                  3.2 Penetration & Growth Prospect Mapping
                  3.3 Osteoporosis Drugs - SWOT Analysis
                  3.4 Industry Analysis - Porter’s
                  3.5 Product Pipeline Analysis
                  3.6 Company Market Share, 2015
Chapter 4 Osteoporosis Drugs Product Estimates & Trend Analysis
                  4.1 Osteoporosis Drugs Market: Product Movement Analysis
                  4.2 Branded
                     4.2.1 Branded market, 2014 - 2025 (USD Million)
                     4.2.2 Bisphosphonates
                           4.2.2.1 Bisphosphonates market, 2014 - 2025 (USD Million)
                     4.2.3 Parathyroid Hormone Therapy
                           4.2.3.1 Parathyroid hormone therapy market, 2014 - 2025 (USD Million)
                     4.2.4 Calcitonin
                           4.2.4.1 Calcitonin market, 2014 - 2025 (USD Million)
                     4.2.5 Selective Estrogen Inhibitors Modulator (SERM)
                           4.2.5.1 SERM market, 2014 - 2025 (USD Million)
                     4.2.6 Rank Ligand Inhibitors
                           4.2.6.1 Rank ligand Inhibitors market, 2014 - 2025 (USD Million)
                     4.2.7 Others
                           4.2.7.1 Others market, 2014 - 2025 (USD Million)
                  4.3 Generic
                     4.3.1 Generic market, 2014 - 2025 (USD Million)
Chapter 5 Osteoporosis Drugs Regional Estimates & Trend Analysis, by Product
                  5.1 Osteoporosis drugs market share by region, 2015 & 2025
                  5.2 North America
                     5.2.1 North America osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.2.2 U.S.
                           5.2.2.1 U.S. osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.2.3 Canada
                           5.2.3.1 Canada osteoporosis drugs market, 2014 - 2025 (USD Million)
                  5.3 Europe
                     5.3.1 Europe osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.3.2 UK
                           5.3.2.1 UK osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.3.3 Germany
                           5.3.3.1 Germany osteoporosis drugs market, 2014 - 2025 (USD Million)
                  5.4 Asia Pacific
                     5.4.1 Asia Pacific osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.4.2 Japan
                           5.4.2.1 Japan osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.4.3 China
                           5.4.3.1 China osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.4.4 India
                           5.4.4.1 India osteoporosis drugs market, 2014 - 2025 (USD Million)
                  5.5 Latin America
                     5.5.1 Latin America osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.5.2 Brazil
                           5.5.2.1 Brazil osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.5.3 Mexico
                           5.5.3.1 Mexico osteoporosis drugs market, 2014 - 2025 (USD Million)
                  5.6 MEA
                     5.6.1 MEA osteoporosis drugs market, 2014 - 2025 (USD Million)
                     5.6.2 South Africa
                           5.6.2.1 South Africa osteoporosis drugs market, 2014 - 2025 (USD Million)
Chapter 6 Competitive Landscape
                  6.1 Strategy framework
                  6.2 Market participation categorization
                  6.3 Company Profiles
                     6.3.1 Pfizer, Inc.
                           6.3.1.1 Company overview
                           6.3.1.2 Financial performance
                           6.3.1.3 Geographic Foothold
                           6.3.1.4 Product benchmarking
                           6.3.1.5 Strategic initiatives
                     6.3.2 F.Hoffmann La Roche
                           6.3.2.1 Company overview
                           6.3.2.2 Financial performance
                           6.3.2.3 Geographic Foothold
                           6.3.2.4 Product benchmarking
                           6.3.2.5 Strategic initiatives
                     6.3.3 Teva Pharmaceuticals
                           6.3.3.1 Company overview
                           6.3.3.2 Financial performance
                           6.3.3.3 Geographic Foothold
                           6.3.3.4 Product benchmarking
                     6.3.4 Novartis AG
                           6.3.4.1 Company overview
                           6.3.4.2 Financial performance
                           6.3.4.3 Geographic Foothold
                           6.3.4.4 Product benchmarking
                           6.3.4.5 Strategic initiatives
                     6.3.5 Merck & Co AG
                           6.3.5.1 Company overview
                           6.3.5.2 Financial Performance
                           6.3.5.3 Geographic Foothold
                           6.3.5.4 Product benchmarking
                           6.3.5.5 Strategic initiatives
                     6.3.6 Amgen, Inc.
                           6.3.6.1 Company overview
                           6.3.6.2 Financial performance
                           6.3.6.3 Geographic Foothold
                           6.3.6.4 Product benchmarking
                           6.3.6.5 Strategic initiatives
                     6.3.7 Allergan plc
                           6.3.7.1 Company overview
                           6.3.7.2 Financial performance
                           6.3.7.3 Geographic Foothold
                           6.3.7.4 Product benchmarking
                           6.3.7.5 Strategic initiatives
                     6.3.8 GlaxoSmithKline
                           6.3.8.1 Company overview
                           6.3.8.2 Financial performance
                           6.3.8.3 Geographic Foothold
                           6.3.8.4 Product benchmarking
                           6.3.8.5 Strategic initiatives
                     6.3.9 Eli Lilly and Company
                           6.3.9.1 Company overview
                           6.3.9.2 Financial performance
                           6.3.9.3 Geographic Foothold
                           6.3.9.4 Product Benchmarking
                           6.3.9.5 Strategic initiatives

List of Tables

TABLE 1 North America osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 2 U.S. osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 3 Canada osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 4 Europe osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 5 UK osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 6 Germany osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 7 Asia Pacific osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 8 Japan osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 9 China osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 10 India osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 11 Latin America osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 12 Brazil osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 13 Mexico osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 14 MEA osteoporosis drugs market, by product, 2014 - 2025 (USD Million)
TABLE 15 South Africa osteoporosis drugs market, by product, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & Growth Prospect Mapping
FIG. 7 Osteoporosis Drugs SWOT Analysis
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Porter’s Five Forces Analysis
FIG. 10 Company Market Share,2015
FIG. 11 Osteoporosis drugs market product outlook key takeaways
FIG. 12 Osteoporosis drugs market: Type movement analysis
FIG. 13 Branded market, 2014 - 2025 (USD Million)
FIG. 14 Bisphosphonates market, 2014 - 2025 (USD Million)
FIG. 15 Parathyroid hormone therapy market, 2014 - 2025 (USD Million)
FIG. 16 Calcitonin market, 2014 - 2025 (USD Million)
FIG. 17 SERM market, 2014 - 2025 (USD Million)
FIG. 18 Rank ligand Inhibitors market, 2014 - 2025 (USD Million)
FIG. 19 Others market, 2014 - 2025 (USD Million)
FIG. 20 Generic market, 2014 - 2025 (USD Million)
FIG. 21 Regional market place: Key takeaways
FIG. 22 Regional outlook, 2015 & 2025
FIG. 23 North America osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 24 U.S. osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 25 Canada osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 26 Europe osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 27 UK osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 28 Germany osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 29 Asia Pacific osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 30 Japan osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 31 China osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 32 India osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 33 Latin America osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 34 Brazil osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 35 Mexico osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 36 MEA osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 37 South Africa osteoporosis drugs market, 2014 - 2025 (USD Million)
FIG. 38 Strategy framework
FIG. 39 Participant categorization